StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
INDOAMIN.NS$129.62+2.14%
Fair $129.62+0.0%

INDOAMIN.NS

Indo Amines Limited

Basic Materials / ChemicalsNSE

$129.62

+2.72 (+2.14%)

Fairly Valued+0.0%Fair Value $129.62Fund rank 23/100 · Data gapFallback financials|
SA 54/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $3.6M · quality 34.3/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 13/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

54/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · INDOAMIN.NSLocal privado en este navegador · Indo Amines Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$9.4B

P/E

12.0x

↓

EV/EBITDA

8.3x

↓

ROE

20.2%

↑

Gross Margin

33.7%

↑

Debt/Equity

0.79

↑
52-Week Range$130
$82$176

TradingView lightweight chart

INDOAMIN.NS price, volumen y niveles de valoración

Último $129.62Periodo +14.4%
Fair value: $129.62

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+7.2%

FCF CAGR

—

FCF margin

0.0%

FCF / Net income

0.00x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $11.60B · net income $793.3M · FCF $3.6M

2023-FY → 2026-FY

Gross margin

33.7%+9.3% pts

Operating margin

8.7%+0.9% pts

Net margin

6.8%+2.5% pts

FCF margin

0.0%+1.2% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$11.60B$11.60B$10.79B$9.43B$9.41B
Net Income$793.3M$793.3M$559.0M$427.5M$408.8M
EBITDA$1.51B$1.51B$1.16B$938.8M$890.1M
EPS10.7910.797.705.925.78
Gross Margin33.7%33.7%32.2%23.3%24.5%
Operating Margin8.7%8.7%7.8%7.2%7.9%
Net Margin6.8%6.8%5.2%4.5%4.3%
Balance Sheet
Debt/Equity0.790.790.900.821.03
Cash Flow
Free Cash Flow$3.6M$3.6M$-477.8M$391.2M$-109.8M
Returns
ROE20.2%20.2%17.6%16.2%18.1%
Valuation
P/E12.0112.0115.2524.0013.85
EV/EBITDA8.318.319.7513.208.90
P/B2.432.432.683.882.51
Growth & Yield
Revenue Growth7.5%7.5%14.3%0.2%—
EPS Growth40.1%40.1%30.1%2.4%—
Dividend Yield0.4%0.4%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

2.2%

fácil

EPS terminal req.

$11.50

Spread vs growth

38.0%

5Y implied EPS CAGR

5.2%

razonable

EPS terminal req.

$13.92

Spread vs growth

34.9%

10Y implied EPS CAGR

7.6%

razonable

EPS terminal req.

$22.41

Spread vs growth

32.5%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -10.3%

Total return

-10.3%

Start / end P/E

18.8x → 12.0x

EPS bridge

7.70 → 10.79

Residual

-14.5%

EPS growth+40.1%
Multiple rerating-36.2%
Dividend+0.4%
Residual / FX / buybacks / cross-term-14.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.